Heart pill trial aims to reverse damage in enlarged hearts

NCT ID NCT07270367

First seen Dec 11, 2025 · Last updated May 16, 2026 · Updated 15 times

Summary

This study tests whether the drug finerenone can improve heart structure and function in 156 adults with an enlarged left side of the heart and risk factors for heart and kidney disease. Participants will take either finerenone or a placebo daily for 12 months and undergo heart scans at the start and end of the study. The goal is to see if finerenone, added to standard care, can reduce heart stiffness and improve pumping ability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cambride Cardiac Care Centre

    Cambridge, Ontario, N1R6V6, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Diagnostic Assessment Centre

    Toronto, Ontario, M1S4N6, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • North York Diagnostic and Cardiac Centre

    North York, Ontario, M6B3H7, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.